Back to Search
Start Over
Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemotherapy and radiotherapy
- Source :
- JCI Insight. 5
- Publication Year :
- 2020
- Publisher :
- American Society for Clinical Investigation, 2020.
-
Abstract
- Pancreatic ductal adenocarcinoma (PDAC) has dismal 5-year survival (
- Subjects :
- Adult
Male
0301 basic medicine
Stromal cell
endocrine system diseases
FOLFIRINOX
medicine.medical_treatment
Leucovorin
Gene Expression
Adenocarcinoma
Irinotecan
03 medical and health sciences
0302 clinical medicine
Pancreatic cancer
Antineoplastic Combined Chemotherapy Protocols
Tumor Microenvironment
Humans
Medicine
Pancreas
Neoadjuvant therapy
Aged
Chemotherapy
Tumor microenvironment
Radiotherapy
business.industry
Cancer
General Medicine
Middle Aged
medicine.disease
Combined Modality Therapy
Neoadjuvant Therapy
Oxaliplatin
Pancreatic Neoplasms
Radiation therapy
030104 developmental biology
030220 oncology & carcinogenesis
Cancer research
Keratins
Female
Fluorouracil
Transcriptome
business
Research Article
Carcinoma, Pancreatic Ductal
Subjects
Details
- ISSN :
- 23793708
- Volume :
- 5
- Database :
- OpenAIRE
- Journal :
- JCI Insight
- Accession number :
- edsair.doi.dedup.....29497f37e6cae6cd606313c81575dd89
- Full Text :
- https://doi.org/10.1172/jci.insight.130362